Home Health Covid, Iss: regions classified as high risk from 2 to 5

Covid, Iss: regions classified as high risk from 2 to 5

0
30

These are Emilia Romagna, Lazio, Marche, Puglia and Veneto. The remaining 16 regions and autonomous provinces are classified as moderate risk. “The increase in the circulation of the virus is starting to continue,” said the Director of Prevention of the Ministry of Health, Gianni Rezza.

Subscribe to our newsletter to stay informed

This week, five regions have been classified as high-risk in the weekly Iss-Ministry of Health monitoring the progress of the Covid-19 epidemic in Italy. Three more than last week. These are Emilia Romagna, Lazio, Marche, Puglia and Veneto. The remaining 16 regions and autonomous provinces are classified as moderate risk. (COVID: LATEST NEWS LIVE – COVID VACCINE: DATA AND IMAGES ON ADMINISTRATIONS IN ITALY, REGION BY REGION)

Rezza: “Increased virus circulation begins to persist”

“This week there has been an increase in the incidence of Covid cases in our country and the incidence has been set at 325 per 100 thousand inhabitants: so there is a significant increase compared to the previous week”. This was stated by the Director of Prevention of the Ministry of Health, Gianni Rezza, who commented on the data related to the weekly monitoring. “Given the increase in the rate of viral circulation, which is now starting to become quite sustained, it is important to remain cautious and especially to carry out the booster dose of vaccines. This mainly concerns people at risk of avoiding the most serious disease ,” he added.

“Tendency to increase hospital occupancy”

As for the situation in hospitals, Rezza explains that “there is a trend towards an increase in the occupancy of places in the medical sector, while we are far from a congestion threshold in intensive care, which remains stable in terms of employment. ” . Also for the RT: “we notice a tendency to rise and we are now at the limit of the epidemic threshold, ie to 1”, he emphasized.

Source: TG 24 Sky

NO COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here